Search research articles
Contact Us
Filters
Showing results (1-10 of 161) with videos related to
Page
of 17
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
June 22, 2026
The Italian National Health Service: still alive for long?
Livio Garattini
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 23, 2006
Should we really worry about "launch delays" of new drugs in OECD countries?
Livio Garattini, Simone Ghislandi
Journal of the Royal Society of Medicine
|
June 16, 2018
Dual practice of hospital staff doctors: hippocratic or hypocritic?
Livio Garattini, Anna Padula
Journal of the Royal Society of Medicine
|
September 10, 2016
European Medicines Agency: leave the UK but remain the same
Livio Garattini, Alessandro Curto
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 20, 2024
Obesity epidemic in European countries: from an unaddressed risk factor to a medicalized disease?
Livio Garattini, Giovanni Fattore
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
August 24, 2019
HTA for pharmaceuticals in Europe: will the mountain deliver a mouse?
Livio Garattini, Anna Padula
Journal of the Royal Society of Medicine
|
January 14, 2017
Cholesterol-lowering drugs: science and marketing
Livio Garattini, Anna Padula
European Journal of Internal Medicine
|
October 4, 2018
English and Italian national health services: Time for more patient-centered primary care?
Livio Garattini, Anna Padula
Pharmacoeconomics
|
June 29, 2019
Comment on: 'The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study'
Livio Garattini, Anna Padula
Health Policy (Amsterdam, Netherlands)
|
November 25, 2010
Influenza vaccine for healthy adult workers: an issue for health authorities or employers?
Livio Garattini, Daniela Koleva
Page
of 17
Search research articles
Search
Showing results (1-10 of 161) with videos related to
Sort By:
Page
of 17
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
June 22, 2026
The Italian National Health Service: still alive for long?
Livio Garattini
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 23, 2006
Should we really worry about "launch delays" of new drugs in OECD countries?
Livio Garattini, Simone Ghislandi
Journal of the Royal Society of Medicine
|
June 16, 2018
Dual practice of hospital staff doctors: hippocratic or hypocritic?
Livio Garattini, Anna Padula
Journal of the Royal Society of Medicine
|
September 10, 2016
European Medicines Agency: leave the UK but remain the same
Livio Garattini, Alessandro Curto
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 20, 2024
Obesity epidemic in European countries: from an unaddressed risk factor to a medicalized disease?
Livio Garattini, Giovanni Fattore
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
August 24, 2019
HTA for pharmaceuticals in Europe: will the mountain deliver a mouse?
Livio Garattini, Anna Padula
Journal of the Royal Society of Medicine
|
January 14, 2017
Cholesterol-lowering drugs: science and marketing
Livio Garattini, Anna Padula
European Journal of Internal Medicine
|
October 4, 2018
English and Italian national health services: Time for more patient-centered primary care?
Livio Garattini, Anna Padula
Pharmacoeconomics
|
June 29, 2019
Comment on: 'The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study'
Livio Garattini, Anna Padula
Health Policy (Amsterdam, Netherlands)
|
November 25, 2010
Influenza vaccine for healthy adult workers: an issue for health authorities or employers?
Livio Garattini, Daniela Koleva
Page
of 17